Pacira BioSciences, Inc. — Director's Dealing 2012

Aug 21, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2012-08-17

Reporting Person: PACE GARY W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-17	Stock Option (right to buy)	$16.67	A	70000	Acquired	2022-08-16	Common Stock (70000)	Direct

Footnotes

F1: The option vests and becomes exercisable as to 25% of the shares on August 17, 2013 and as to the remaining shares over 36 months in successive equal monthly installments